Severity: Warning
Message: file_get_contents(https://...@pubfacts.com&api_key=b8daa3ad693db53b1410957c26c9a51b4908&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
Filename: helpers/my_audit_helper.php
Line Number: 176
Backtrace:
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 176
Function: file_get_contents
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 250
Function: simplexml_load_file_from_url
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3122
Function: getPubMedXML
File: /var/www/html/application/controllers/Detail.php
Line: 575
Function: pubMedSearch_Global
File: /var/www/html/application/controllers/Detail.php
Line: 489
Function: pubMedGetRelatedKeyword
File: /var/www/html/index.php
Line: 316
Function: require_once
Background: For over two years, naltrexone has been available as a treatment for opioid dependence. It is a useful addition to the limited range of available drug treatments.
Objective: This article outlines the major pharmacological features of naltrexone and provides some guidelines on its use in opioid dependence for general practitioners.
Discussion: In the past, options for GPs in assisting opioid dependent patients have been limited, and referral to alcohol and drug programs has usually been the most practical response. Over the past five years there has been a significant increase in the range of available treatments. One relatively recent addition to the options is the drug naltrexone (Revia) which can be used by the GP with rewarding results if patients are carefully chosen and safety guidelines for the drug are adhered to.
Download full-text PDF |
Source |
---|
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!